Roivant Sciences Management
Management criteria checks 2/4
Roivant Sciences' CEO is Matt Gline, appointed in Jan 2021, has a tenure of 3.33 years. total yearly compensation is $48.98M, comprised of 1.5% salary and 98.5% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth $12.97M. The average tenure of the management team and the board of directors is 3.3 years and 2.7 years respectively.
Key information
Matt Gline
Chief executive officer
US$49.0m
Total compensation
| CEO salary percentage | 1.5% |
| CEO tenure | 3.3yrs |
| CEO ownership | 0.1% |
| Management average tenure | 3.3yrs |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
Roivant Sciences: $7bn Televant Sale Sets It Up For Long-Term Success
Mar 18We Believe Roivant Sciences' (NASDAQ:ROIV) Earnings Are A Poor Guide For Its Profitability
Feb 21
These Analysts Just Made A Decent Downgrade To Their Roivant Sciences Ltd. (NASDAQ:ROIV) EPS Forecasts
Nov 15Are Investors Undervaluing Roivant Sciences Ltd. (NASDAQ:ROIV) By 21%?
Apr 26Broker Revenue Forecasts For Roivant Sciences Ltd. (NASDAQ:ROIV) Are Surging Higher
Nov 22Newsflash: Roivant Sciences Ltd. (NASDAQ:ROIV) Analysts Have Been Trimming Their Revenue Forecasts
Sep 29Roivant Sciences Ltd. (NASDAQ:ROIV) Analysts Are Reducing Their Forecasts For This Year
Aug 21Roivant Sciences GAAP EPS of -$0.48, revenue of $4.32M
Aug 15An Intrinsic Calculation For Roivant Sciences Ltd. (NASDAQ:ROIV) Suggests It's 22% Undervalued
Aug 12Roivant Sciences Ltd. (NASDAQ:ROIV) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Jun 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | US$4b |
| Sep 30 2023 | n/a | n/a | -US$1b |
| Jun 30 2023 | n/a | n/a | -US$1b |
| Mar 31 2023 | US$49m | US$725k | -US$1b |
| Dec 31 2022 | n/a | n/a | -US$1b |
| Sep 30 2022 | n/a | n/a | -US$1b |
| Jun 30 2022 | n/a | n/a | -US$1b |
| Mar 31 2022 | US$30m | US$725k | -US$845m |
| Dec 31 2021 | n/a | n/a | -US$1b |
| Sep 30 2021 | n/a | n/a | -US$1b |
| Jun 30 2021 | n/a | n/a | -US$888m |
| Mar 31 2021 | US$8m | US$350k | -US$809m |
Compensation vs Market: Matt's total compensation ($USD48.98M) is above average for companies of similar size in the US market ($USD8.45M).
Compensation vs Earnings: Matt's compensation has been consistent with company performance over the past year.
CEO
Matt Gline (39 yo)
3.3yrs
Tenure
US$48,978,826
Compensation
Mr. Matthew Gline, also known as Matt, is Chief Executive Officer of Roivant Sciences Ltd. since January 26, 2021 and its Director since September 30, 2021. He has been Chief Executive Officer of Roivant S...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.3yrs | US$48.98m | 0.14% $ 13.0m | |
| President & COO | 5.5yrs | US$48.49m | 0.027% $ 2.4m | |
| President | 3.3yrs | US$48.93m | 0.66% $ 59.7m | |
| Chief Financial Officer | 2.7yrs | no data | 0.014% $ 1.3m | |
| Chief Accounting Officer | 5.8yrs | no data | 0.011% $ 966.5k | |
| Chief Technology Officer | no data | no data | no data | |
| General Counsel | no data | no data | no data | |
| Head of People | 2.3yrs | no data | no data | |
| Head of Global Transactions & Risk Management | no data | no data | no data | |
| Executive Vice President of Roivant Health | no data | no data | no data | |
| Chief Operating Officer of Roivant Platforms | no data | no data | no data | |
| Chief Development Officer | 2yrs | no data | no data |
3.3yrs
Average Tenure
43.5yo
Average Age
Experienced Management: ROIV's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.7yrs | US$48.98m | 0.14% $ 13.0m | |
| President | less than a year | US$48.93m | 0.66% $ 59.7m | |
| Independent Director | 1.2yrs | US$2.34k | 0.00061% $ 55.3k | |
| Independent Director | 10.3yrs | US$391.03k | 0.0065% $ 586.0k | |
| Independent Director | 2.7yrs | US$394.31k | 0.0074% $ 671.2k | |
| Independent Director | 4.3yrs | US$401.03k | 1.23% $ 111.4m | |
| Independent Director | 1.9yrs | US$654.02k | 0.00059% $ 53.4k | |
| Independent Chairman | 10.3yrs | US$403.53k | 0.0078% $ 703.8k |
2.7yrs
Average Tenure
49yo
Average Age
Experienced Board: ROIV's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.